Recall archive / FDA drug enforcement

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials eac... — FDA record D-0175-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jan 13, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
Reason: Short Fill
Classification: Class II
Recalling firm: Nephron Sc Inc
Quantity: 387,000 vials
Agency-reported status: Terminated
Source record identifier: D-0175-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	Lot #: 126451 Exp. 04/30/2023

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Nationwide within the United States including Puerto Rico. Guatamala

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date: Feb 1, 2023
Recall initiation date: Jan 13, 2023
Center classification date: Jan 23, 2023
Termination date: Oct 11, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.